Baba Ramdev’s Patanjali Ayurved, a prominent Indian consumer goods company, has made its foray into the general insurance industry through the acquisition of a majority stake in Magma General Insurance. According to the agreement, Patanjali Ayurved and DS Group, the maker of Rajnigandha, will purchase Magma General Insurance from Sanoti Properties LLP for a valuation … Read more
You might be familiar with India’s richest billionaires, but how much do you know about their kids (other than the news about their fancy and luxurious weddings and lifestyle)? The next-generation business tycoons are making it big in their respective fields and as we move into the most crucial phase of Indian business, this current … Read more
Mukesh Ambani, Lakshmi Mittal, Adar Poonawalla, and Hinduja Brothers – Indian billionaires are among some of the richest people in the world. While these billionaires are known for their net worth and business turnover, they also own luxurious and lavish houses in India and abroad. From some of the most luxurious mansions to the most … Read more
Serum Institute of India chief executive officer Adar Poonawalla. File. | Photo Credit: Kamal Narang Serum Institute of India’s Chief Executive Officer Adar Poonawalla has said their Covovax vaccine will get approval as a booster against COVID-19 in the next 10 to 15 days. The vaccine works very well against the Omicron variant of coronavirus, … Read more
If one looks at the sectors that have given positive returns in 2022 so far, non-bank finance companies will find themselves in the list. But the one stock in this pack that has turned out to be the “darling” of Dalal Street is Ltd. Investor interest in the stock gained traction after billionaire Adar Poonawalla … Read more
The transformation of into has turned out to be magical for minority shareholders as the midcap NBFC stock has turned multibagger with over 700 per cent return in just two years. The non-stop rally in the stock began before ‘vaccine king’ Adar Poonawalla announced buying over 60 per cent stake in the company on Feb … Read more
Serum Institute of India (SII) CEO Adar Poonawalla on Monday said he is appealing to multilateral organisations and world leaders to come up with a draft about learnings from the COVID-19 pandemic to strengthen health systems globally. The learnings from the global pandemic would help in addressing inequity in the health systems that are prevalent … Read more
Serum Institute of India CEO Adar Poonawalla on Friday warned against the return to the business-as-usual approach, saying we “can’t afford to put a price tag on the life of a citizen” as the pandemic is not behind us yet. The chief executive defended his call for lowering the vaccination gap to six months from … Read more
Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard people against emerging COVID variants, according to its CEO Adar Poonawalla. Recalling that they could not meet the commitment of exporting vaccines in … Read more
Serum Institute of India has cut the price of the Covishield precaution (booster) dose at private hospitals by more than half, a day before booster shots become available to all Indian adults, CEO Adar Poonawalla announced. The price of a single dose has been slashed to Rs 225 from Rs 600 earlier. The decision was … Read more